BIO CEO John Crowley speaks with FDA Commissioner Marty Makary at the BIO conference in Boston. Allison DeAngelis/STAT By Allison DeAngelis and Elizabeth Cooney June 17, 2025 ...

The BIO conference technically kicks off today, but the activity started over the weekend. On Sunday, I stopped by the BIOCHINA conference in Boston, a small-but-growing offshoot of a Chinese ...

CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The ...

Renasant Bio has launched with $54.5 million in seed financing to develop treatments for autosomal dominant polycystic kidney disease (ADPKD), which causes severe kidney damage.